Uvision 360, inc.(hereafter uvision) performed functional testing at the uvision 360 office.The device did not perform as intended, however, the issue had already been addressed by uvision through an update to the design.This improvement was released after the sale date of this system.Uvision did not consider this a medical device reportable event and therefore did not report this complaint when initially received due to the following: the malfunction was an isolated event as the improvement was released to address the malfunction type after the malfunction occurred.No patient harm was observed as a result of the malfunction.Based on the medical advisor's qualified opinion, this malfunction was unlikely to cause serious harm or death to a patient if this malfunction were to recur.The malfunction was evaluated as a possible hazardous situation and failure mode of the device through the product hazard analysis and dfmea.All risks associated with this malfunction were deemed acceptable.The maude database was reviewed for the product code hih and it was found that no events were reported for similar devices, as defined by fda guidance "medical device reporting for manufacturers guidance for industry and food and drug administration staff 2016." following an fda routine inspection performed in februrary 2023, the inspector issued an fda 483 identifying this complaint as a reportable malfunction.
|